Document:

EX-10.10

 Exhibit 10.10 

CELL BIOSCIENCES, INC. 

AMENDED AND RESTATED EXECUTIVE EMPLOYMENT AGREEMENT 

for 
 Tim Harkness

 This Amended and Restated Executive Employment Agreement (the “Agreement”), made between Cell Biosciences, Inc. (the
“Company”) and Tim Harkness (the “Executive”) (collectively, the “Parties”), amends, restates and supersedes in its entirety the employment offer letter agreement between the Company and Executive
that was effective as of June 12, 2008 (the “Original Agreement”). This Agreement is effective as of February 3, 2011. 

WHEREAS, Executive is currently employed by the Company as its President and Chief Executive Officer,
pursuant to the Original Agreement; and 
 WHEREAS, Company desires to continue to employ Executive as
its President and Chief Executive Officer, and Executive is willing to continue such employment by Company, on the amended and restated terms and conditions set forth in this Agreement. 

NOW, THEREFORE, in consideration of the mutual promises and covenants contained herein and
for other good and valuable consideration, the receipt and sufficiency of which is hereby acknowledged, the Parties hereto agree as follows: 

1. Employment by the Company. 

1.1 Position. Executive shall serve as the Company’s President and Chief Executive Officer. During the term of Executive’s
employment with the Company, Executive will devote Executive’s best efforts and substantially all of Executive’s business time and attention to the business of the Company, except for approved vacation periods and reasonable periods of
illness or other incapacities permitted by the Company’s general employment policies. 
 1.2 Duties and Location. Executive
shall perform such duties as are required by the Company’s Board of Directors (“Board”), to whom Executive will report. Executive will serve as a member of the Board until the earlier of the severance of Executive’s
employment for any reason, or Executive’s death. Executive’s primary office location shall be the Company’s Santa Clara, California office. 

1.3 Policies and Procedures. The employment relationship between the Parties shall be governed by the general employment policies and
practices of the Company, except that when the terms of this Agreement differ from or are in conflict with the Company’s general employment policies or practices, this Agreement shall control. 

 2. Compensation. 

2.1 Salary. For services to be rendered hereunder, Executive shall receive a base salary at the rate of four hundred thousand
($400,000) per year (the “Base Salary”), payable in accordance with customary Company payroll procedures in effect for other executive employees and subject to standard payroll deductions and withholdings. Executive’s Base
Salary shall be subject to review and adjustment on an annual basis, subject to the terms set forth herein. Executive shall not receive any additional compensation for Executive’s service as a member of the Board. 

2.2 Bonus. Executive will be eligible to earn an annual cash bonus targeted at sixty percent (60%) of Executive’s Base Salary
(the “Annual Bonus”), which, if earned, will be paid by the end of the first quarter of the following calendar year. Executive will be eligible to receive the Annual Bonus based upon the Company meeting and/or exceeding specified
corporate sales goals (the “Sales Goals”) and Executive’s achievement of Chief Executive Officer-specific goals (the “CEO Goals”). The Sales Goals and CEO Goals will be mutually agreed upon by Executive and the
Board. The Sales Goals and CEO Goals will be established no later than March 15 for each calendar year. Except as otherwise provided in Section 7 hereof, Executive must remain an active employee through the last day of the applicable
fiscal year to be eligible to receive the Annual Bonus. 
 3. Standard Company Benefits. Executive shall be entitled to participate
in all employee benefit programs for which Executive is eligible under the terms and conditions of the benefit plans that may be in effect from time to time and provided by the Company to its employees. The Company reserves the right to cancel or
change the benefit plans or programs it offers to its employees at any time. If Executive elects to continue any current COBRA health insurance coverage rather than participate in the Company’s group health insurance plans, the Company will
reimburse Executive for Executive’s monthly health insurance premiums (for Executive, Executive’s spouse and any covered dependents) up to the maximum dollar amount the Company would contribute to Executive’s health insurance coverage
if Executive elected to participate in the Company’s group plan. 
 4. Vacation. Executive will enjoy four (4) weeks of
paid time off each year, the use and accrual of which will be governed in accordance with Company policy. 
 5. Expenses. The Company
will reimburse reasonable business-related expenses incurred by Executive in accordance with applicable Company policies, including but not limited to cellular phone/PDA expenses. 

  
 2. 

 6. Equity. 

6.1 Option Grants. Subject to the Compensation Committee of the Company’s Board (the “Compensation Committee”) and
the Board’s annual review and approval, Executive may be eligible to receive stock options to purchase shares of Common Stock, as determined by the Compensation Committee and the Board, in their sole discretion. 

6.2 Acceleration.  

(i) Single Trigger Benefits. In the event a Change of Control (as defined below) occurs at any time during Executive’s
employment, the vesting of any unvested shares or options then held by Executive shall be accelerated by six (6) months. 
 (ii)
Double Trigger Benefits. If, within one (1) month before and thirty-six (36) months after a Change of Control, Executive’s employment is terminated by the Company without Cause (as defined below) or Executive resigns for Good
Reason (as defined below) (each a “Change of Control Termination”), one hundred percent (100%) of all shares or stock options which are not vested at the time of Executive’s termination will accelerate and become fully
vested. 
 7. Termination of Employment; Severance. 

7.1 At-Will Employment. Executive’s employment relationship is at-will. Either Executive or the Company may terminate the
employment relationship at any time, with or without Cause or advance notice. 
 7.2 Termination Without Cause; Resignation for Good
Reason. If, at any time other than during the period commencing one (1) month prior to the effective date of a Change of Control and ending thirty-six (36) months following the effective date of the Change of Control, the Company
terminates the Executive’s employment without Cause, or Executive resigns for Good Reason, and such termination constitutes a Separation from Service (as defined below), the Company shall provide the Executive with the following severance
benefits: 
 (i) A cash severance benefit in an amount equal to the sum of (i) twelve (12) months of the Executive’s
Base Salary, (ii) the prior year’s Annual Bonus amount actually earned by the Executive (if not yet paid), (iii) one hundred percent (100%) of the Executive’s Target Bonus (as defined below) for the year in which the
termination occurs, and (iv) a pro rata portion of the Executive’s Target Bonus based on the number of months worked during the year in which the termination occurs, subject to withholdings and deductions, which aggregate amount shall be
paid in a lump sum on the first regular payroll date following the effective date of the Executive’s release of claims; provided, however, the payment shall be made no later than March 15 of the year following the year of
termination; and 
 (ii) Provided that the Executive is eligible to continue coverage under a health, dental, or vision plan
sponsored by the Company under the Consolidated Omnibus Budget Reconciliation Act of 1985 (“COBRA”) at the time of the Executive’s 

  
 3. 

 
termination and timely elects such continuation of coverage under COBRA, the Company will pay COBRA premiums on behalf of the Executive and his eligible dependents following the Executive’s
termination of employment (but in no event longer that the date on which the Executive or his eligible dependents cease to be eligible for COBRA). Notwithstanding the previous sentence, if the Company determines in its sole discretion that it cannot
provide the foregoing COBRA benefit without potentially violating applicable law (including, without limitation, Section 2716 of the Public Health Service Act), the Company shall in lieu thereof provide to the Executive a taxable monthly
payment in an amount equal to the monthly COBRA premium that the Executive would be required to pay to continue the Executive’s group health coverage in effect on the date of the Executive’s termination (which amount shall be based on the
premium for the first month of COBRA coverage), which payments shall be made regardless of whether the Executive elects COBRA continuation coverage and shall end on the earlier of (x) the date upon which the Executive obtains other employment
or (y) the last day of the twelfth (12th) calendar month following the Executive’s termination date. Upon the conclusion of such period of insurance premium payments made by the
Company, the Executive will be responsible for the entire payment of premiums required under COBRA for the duration of the COBRA period. No provision of this Agreement will affect the continuation coverage rules under COBRA, except that the
Company’s payment of any applicable insurance premiums will be credited as payment by the Executive for purposes of the Executive’s payment required under COBRA. Therefore, the period during which the Executive may elect to continue the
Company’s health, dental, or vision plan coverage at his own expense under COBRA, the length of time during which COBRA coverage will be made available to the Executive, and all other rights and obligations of the Executive under COBRA (except
the obligation to pay insurance premiums that the Company pays in accordance with the foregoing) will be applied in the same manner that such rules would apply in the absence of this Agreement. For purposes of this Section 7.2(ii),
(i) references to COBRA shall be deemed to refer also to analogous provisions of state law and (ii) any applicable insurance premiums that are paid by the Company shall not include any amounts payable by the Executive under an Internal
Revenue Code Section 125 health care reimbursement plan, which amounts, if any, are the sole responsibility of the Executive. 

(iii) Extension of the period of time for the Executive to exercise each of his then vested and outstanding Company stock options
until the earlier of (i) twelve (12) months after his termination date and (ii) the expiration date of each option as set forth in the applicable stock option agreement issued by the Company to the Executive; and 

(iv) Retention of the laptop computer, cellular phone and PDA provided to the Executive by the Company during his employment, provided
that the aggregate value of this Company property (as determined by the Company) is less than $3,000. 
 7.3 Termination without Cause or
Resignation for Good Reason Following a Change of Control. If the Company terminates the Executive’s employment without Cause, or the Executive resigns for Good Reason, in either case, at any time during the period commencing one
(1) month prior to the effective date of a Change of Control and ending thirty-six (36) months following the effective date of the Change of Control, and provided such termination constitutes a Separation from Service, then the Company
shall provide the Executive with the severance benefits described in Sections 7.2(i)-(iv) above. 

  
 4. 

 8. Section 409A. It is intended that all of the severance benefits and other payments
payable under this Agreement satisfy, to the greatest extent possible, the exemptions from the application of Code Section 409A provided under Treasury Regulations 1.409A-1(b)(4), 1.409A-1(b)(5) and 1.409A-1(b)(9), and this Agreement will be construed to the greatest extent possible as consistent with those provisions, and to the extent no so exempt,
this Agreement (and any definitions hereunder) will be construed in a manner that complies with Section 409A. For purposes of Code Section 409A (including, without limitation, for purposes of Treasury Regulation Section 1.409A-2(b)(2)(iii)), Executive’s right to receive any installment payments under this Agreement (whether severance payments, reimbursements or otherwise) shall be treated as a right to receive a
series of separate payments and, accordingly, each installment payment hereunder shall at all times be considered a separate and distinct payment. Notwithstanding any provision to the contrary in this Agreement, if Executive is deemed by the Company
at the time of Executive’s Separation from Service (as defined below) to be a “specified employee” for purposes of Code Section 409A(a)(2)(B)(i), and if any of the payments upon Separation from Service set forth herein and/or
under any other agreement with the Company are deemed to be “deferred compensation”, then to the extent delayed commencement of any portion of such payments is required in order to avoid a prohibited distribution under Code
Section 409A(a)(2)(B)(i) and the related adverse taxation under Section 409A, such payments shall not be provided to Executive prior to the earliest of (i) the expiration of the six-month period measured from the date of
Executive’s Separation from Service with the Company, (ii) the date of Executive’s death or (iii) such earlier date as permitted under Section 409A without the imposition of adverse taxation. Upon the first business day
following the expiration of such applicable Code Section 409A(a)(2)(B)(i) period, all payments deferred pursuant to this paragraph shall be paid in a lump sum to Executive, and any remaining payments due shall be paid as otherwise provided
herein or in the applicable agreement. No interest shall be due on any amounts so deferred. 
 9. Release of Claims. Payment
and receipt of the severance benefits and/or accelerated vesting benefits provided for herein will be conditioned on Executive’s execution of a standard form of release in the form provided by the Company, within the time provided therein, and
such release must become effective in accordance with its terms, but in all cases the release must become effective within sixty (60) days following the date Executive’s “separation from service” (as defined under Treasury
Regulation Section 1.409A-1(h)). Such release shall include confirmation of Executive’s obligations under any confidentiality and/or proprietary information agreement. 

10. Definitions.  

(i) Cause. For purposes of this Agreement, “Cause” shall mean (i) Executive’s repeated unexplained or
unjustified absence from the Company or gross negligence, willful misconduct, or repeated, willful and flagrant insubordination in the performance of Executive’s duties to the Company as directed by the Board, which remains uncured more than
thirty (30) days following written notice from the Board of its belief that there is Cause for Executive’s termination under this clause (i); (ii) a material and willful commission of any federal or state felony; (iii) commission
of any act of fraud 

  
 5. 

 
that is related to Executive’s personal gain with respect to the Company; or (iv) conviction of a felony or a crime involving moral turpitude causing material harm to the standing and
reputation of the Company, or any willful violation of a Federal or State law that significantly reduces the credibility of the Company, or affects the Company in a materially financial way. No act or failure to act by Executive shall be deemed
“willful” if done or omitted to be done by Executive in good faith and with the reasonable belief that Executive’s act or omission was in the best interest of the Company or consistent with the Company’s policies or the directive
of the Board. 
 (ii) Change of Control. For purposes of this Agreement, “Change of Control” shall have the meaning
given to the term “Change in Control” as set forth in the Company’s 2003 Stock Option/Stock Issuance Plan in effect on the date hereof and as amended and/or restated from time to time. Notwithstanding the foregoing, if the Company or
a successor hereto subsequently determines that any benefits or other payments payable under this Agreement constitute deferred compensation under Section 409A, a “Change of Control” shall be limited to a transaction satisfying the
requirements of Treasury Regulation Sections 1.409A-3(c)(1) (regarding alternative payment schedules) and 1.409A-3(i)(5) (defining a change in control event, without regard to the alternative definitions thereunder). 

(iii) Good Reason. For purposes of this Agreement, “Good Reason” shall mean Executive’s
resignation of employment because any of the following occurs without Executive’s consent which remains uncured more than thirty (30) days following written notice from Executive to the Board specifying the basis for Executive’s
belief that Executive has Good Reason to resign: (i) the material diminution of Executive’s duties and responsibilities (such as the loss of oversight responsibility for research and development, marketing or sales components of the
Company’s operations, or Executive’s removal from or failure to be elected (or re-elected) to the Board prior to a Change of Control); (ii) the material reduction of Executive’s Base Salary or Annual Bonus potential, excluding
only reductions of 10% or less (cumulatively) that are made prior to a Change of Control in connection with an across-the-board reduction of all executive officers’ annual base salaries or bonus potential by a percentage at least equal to the
percentage by which Executive’s Base Salary or Annual Bonus potential is reduced; or (iii) the transfer of Executive’s principal place of business for the Company more than 40 miles from the Company’s current Santa Clara,
California location. If Executive resigns for Good Reason because of a material reduction in Executive’s Base Salary or Annual Bonus potential, Executive’s severance pay will be calculated using Executive’s Base Salary and Annual
Bonus percentage in effect immediately before such reduction. 
 (iv) Separation from Service. For purposes of this Agreement,
“Separation from Service” shall mean “separation from service” as defined under Treasury Regulation Section 1.409A-1(h), without regard to any alternative definition thereunder. 

(v) Target Bonus. For purposes of this Agreement, “Target Bonus” shall be equal to the greater of
(i) Executive’s actual Annual Bonus amount paid for the prior calendar year, or (ii) the Annual Bonus percentage as provided in Section 2.2, or as most recently approved by the Board. 

  
 6. 

 11. Proprietary Information Obligations. 

11.1 Confidential Information Agreement. Executive agrees to abide by the Employee Proprietary Information and Inventions Agreement
dated June 16, 2008, between the Company and Executive (the “Confidentiality Agreement”). 
 11.2 Third-Party
Agreements and Information. Executive represents and warrants that Executive’s employment by the Company does not conflict with any prior employment or consulting agreement or other agreement with any third party, and that Executive will
perform Executive’s duties to the Company without violating any such agreement. Executive represents and warrants that Executive does not possess confidential information arising out of prior employment, consulting, or other third party
relationships, that would be used in connection with Executive’s employment by the Company, except as expressly authorized by that third party. During Executive’s employment by the Company, Executive will use in the performance of
Executive’s duties only information which is generally known and used by persons with training and experience comparable to Executive’s own, common knowledge in the industry, otherwise legally in the public domain, or obtained or developed
by the Company or by Executive in the course of Executive’s work for the Company. 
 12. Outside Activities During Employment.

 12.1 Non-Company Business. Executive will be entitled to participate in outside for-profit, not-for-profit and civic activities
during Executive’s employment provided that: (i) Executive shall be limited to participating in no more than a total of three (3) outside boards at any time, all located in the western USA area, and (ii) Executive’s
involvement in outside activities must not unreasonably interfere with Executive’s performance of Executive’s duties hereunder. Executive must obtain the Board’s advance consent before accepting any outside board position, which
consent shall not be unreasonably withheld. 
 12.2 No Adverse Interests. Executive agrees not to acquire, assume or participate in,
directly or indirectly, any position, investment or interest known to be adverse or antagonistic to the Company, its business or prospects, financial or otherwise. 

13. Dispute Resolution; Arbitration. The Company and Executive agree that any dispute or controversy arising out of, relating to, or in
connection with this Agreement, the interpretation, validity, construction, performance, breach, or termination thereof, or Executive’s employment or severance of employment, shall be settled by arbitration to be held in San Francisco,
California, in accordance with the Judicial Arbitration and Mediation Service/Endispute, Inc. (“JAMS”) rules for employment disputes then in effect (the “Rules”). The arbitrator may grant injunctions or other relief
in such dispute or controversy. The decision of the arbitrator shall be final, conclusive and binding on the parties to the arbitration. Judgment may be entered on the arbitrator’s decision in any court having jurisdiction. The arbitrator shall
award the prevailing party all reasonable costs and attorneys’ fees incurred during any such proceeding. The arbitrator shall apply California law to the merits of any dispute or claim. Executive hereby expressly consent to the personal
jurisdiction of the state and federal courts located in San Francisco, California for any action or proceeding arising from or relating to this Agreement or relating to any 

  
 7. 

 
arbitration in which the parties are participants. The parties may apply to any court of competent jurisdiction for a temporary restraining order, preliminary injunction, or other interim or
conservatory relief, as necessary, without breach of this arbitration agreement and without abridgment of the powers of the arbitrator. EXECUTIVE HAS READ AND UNDERSTANDS THIS SECTION, WHICH DISCUSSES ARBITRATION. EXECUTIVE UNDERSTANDS THAT BY
SIGNING THIS AGREEMENT, EXECUTIVE AGREES TO SUBMIT ANY FUTURE CLAIMS ARISING OUT OF, RELATING TO, OR IN CONNECTION EXECUTIVE’S EMPLOYMENT OR TERMINATION THEREOF, OR THE INTERPRETATION, VALIDITY, CONSTRUCTION, PERFORMANCE OR BREACH OF THIS
AGREEMENT, TO BINDING ARBITRATION, AND THAT THIS ARBITRATION CLAUSE CONSTITUTES A WAIVER OF EXECUTIVE’S RIGHT TO A JURY TRIAL AND RELATES TO THE RESOLUTION OF ALL DISPUTES RELATING TO ALL ASPECTS OF EXECUTIVE’S EMPLOYMENT RELATIONSHIP,
INCLUDING BUT NOT LIMITED TO, DISCRIMINATION CLAIMS. 
 14. General Provisions. 

14.1 Notices. Any notices provided must be in writing and will be deemed effective upon the earlier of personal delivery (including
personal delivery by fax) or the next day after sending by overnight carrier, to the Company at its primary office location and to Executive at the address as listed on the Company payroll. 

14.2 Severability. Whenever possible, each provision of this Agreement will be interpreted in such manner as to be effective and valid
under applicable law, but if any provision of this Agreement is held to be invalid, illegal or unenforceable in any respect under any applicable law or rule in any jurisdiction, such invalidity, illegality or unenforceability will not affect any
other provision or any other jurisdiction, but this Agreement will be reformed, construed and enforced in such jurisdiction to the extent possible in keeping with the intent of the parties. 

14.3 Waiver. Any waiver of any breach of any provisions of this Agreement must be in writing to be effective, and it shall not thereby
be deemed to have waived any preceding or succeeding breach of the same or any other provision of this Agreement. 
 14.4 Complete
Agreement. This Agreement, together with the Confidentiality Agreement, constitutes the entire agreement between Executive and the Company with regard to this subject matter and is the complete, final, and exclusive embodiment of the
Parties’ agreement with regard to this subject matter. This Agreement is entered into without reliance on any promise or representation, written or oral, other than those expressly contained herein, and it supersedes any other such promises,
warranties or representations, including, but not limited to, the Original Agreement. It is entered into without reliance on any promise or representation other than those expressly contained herein, and it cannot be modified or amended except in a
writing signed by a duly authorized officer of the Company. 

  
 8. 

 14.5 Counterparts. This Agreement may be executed in separate counterparts, any one of
which need not contain signatures of more than one party, but all of which taken together will constitute one and the same Agreement. 

14.6 Headings. The headings of the paragraphs hereof are inserted for convenience only and shall not be deemed to constitute a part
hereof nor to affect the meaning thereof. 
 14.7 Successors and Assigns. This Agreement is intended to bind and inure to the benefit
of and be enforceable by Executive and the Company, and their respective successors, assigns, heirs, executors and administrators, except that Executive may not assign any of his duties hereunder and he may not assign any of his rights hereunder
without the written consent of the Company, which shall not be withheld unreasonably. 
 14.8 Tax Withholding and Indemnification.
All payments and awards contemplated or made pursuant to this Agreement will be subject to withholdings of applicable taxes in compliance with all relevant laws and regulations of all appropriate government authorities. Executive acknowledges
and agrees that the Company has neither made any assurances nor any guarantees concerning the tax treatment of any payments or awards contemplated by or made pursuant to this Agreement. Executive has had the opportunity to retain a tax and financial
advisor and fully understands the tax and economic consequences of all payments and awards made pursuant to the Agreement. 
 14.9 Choice
of Law. All questions concerning the construction, validity and interpretation of this Agreement will be governed by the laws of the State of California. 

  
 9. 

 IN WITNESS WHEREOF, the
Parties have executed this Agreement on the day and year first written above. 
  

			
	CELL BIOSCIENCES, INC.
		
	 By:
	 	 /s/ Jason Novi

 
			
	 Name: Jason Novi

	 Title: Chief Financial Officer

	
	EXECUTIVE
	
	 /s/ Tim Harkness

	Tim Harkness

  
 10.EX-10.11

 Exhibit 10.11 
  

 
 1050 Page Mill Road 
 Palo
Alto, CA 94304 
 T: 650-859-1485 
 F: 650-858-1999 

www.cellbiosciences.com 
 June 25, 2008 

Jason B. Novi 
  

	Re:	Offer of Employment with Cell Biosciences, Inc. 

 Dear Jason: 

On behalf of Cell Biosciences, Inc. (the “Company”), I am pleased to offer you employment with the Company as Vice President,
Finance and Chief Financial Officer, reporting to Tim Harkness, CEO. This letter sets out the terms of your employment with the Company, which will start on Friday, June 27, 2008. 

You will be paid a base salary of $225,000 (Two Hundred Twenty-five Thousand dollars) per year in accordance with the Company’s normal
payroll procedure, less standard payroll deductions and withholdings. You will also be eligible to participate in various Company fringe benefit plans. These include access to group health insurance (medical, dental and vision insurance coverage),
401(k), and other benefits the Company may make available and provide to its employees, subject to the terms of the applicable plan. You also will be eligible for vacation and sick leave according to standard Company policy. The Company may also
consider you for bonuses, although the amount of such bonuses, if any, and the criteria for determining the award of such bonuses, shall be in the sole discretion of the Company and you must remain employed by the Company through payment of the
bonus in order to be eligible to receive any bonus payment. 
 We strongly believe that our collective success will depend on the quality of
the people and their equity involvement in the Company in the long term. As such, subject to the approval of the Company’s Board of Directors, you will be granted an option to purchase 140,000 (One Hundred Forty Thousand) shares of Company
common stock under the Company’s 2003 stock option plan at an exercise price equal to the fair market value of that stock on your option grant date. Twenty five percent of the option will vest on the first anniversary of your initial date of
employment. After that one year period, the option will vest at 1/48th per month, and will be subject to the terms and conditions of the Company’s stock option plan and standard form of stock option agreement, which you will be required to
sign as a condition of receiving the option. Your participation in any stock option or employee benefit program is not to be regarded as assuring your continuing employment with the Company for any particular period of time. 

 You should be aware that your employment with the Company is for no special period. As a result,
you are free to resign at any time, for any reason or for no reason. Similarly, the Company is free to conclude its employment relationship with you at any time, with or without cause. Further, this provision cannot be altered or amended absent a
writing signed by you and the Chief Executive Officer of the Company. 
 This agreement, the referenced stock option agreement and the
included Employee Proprietary Information and Inventions Agreement constitute the entire agreement between you and the Company regarding the terms and conditions of your employment, and they supersede all other promises, negotiations,
representations or agreements between you and the Company, whether written or oral. This letter agreement shall be construed and interpreted in accordance with the laws of the State of California. 

You hereby represent that your employment with the Company will not breach any agreement to keep in confidence proprietary information,
knowledge, or data acquired by you in confidence or in trust prior to becoming an employee of the Company, and you will not improperly use or disclose to the Company, or induce the Company to use or disclose, any confidential or proprietary
information or material belonging to any previous employer or others. You further agree to not bring onto the premises of the Company any unpublished documents or any property belonging to any former employer or other person to whom you have an
obligation of confidentiality unless consented to in writing by that former employer or person and the Company. 
 You also must establish
your identity and authorization to work as required by the Immigration Reform and Control Act of 1986 (IRCA). Enclosed is a copy of the Employment Verification Form (I-9), with instructions required by IRCA. Please review this document and bring the
appropriate original documentation on your first day of work. 
 We look forward to working with you at the Company. Please sign and date
this letter on the spaces provided below to acknowledge your acceptance of the terms of this agreement. We look forward to your favorable reply and a productive and enjoyable work relationship. 

Sincerely, 
 Cell Biosciences, Inc. 

 

									
	By:	 	 /s/ Tim Harkness
	 		  	Date: 6/25/08	  	
		 	Tim Harkness, CEO	 		  		  	

 I agree to and accept employment with Cell Biosciences, Inc. on the terms and conditions set forth in this
agreement. 
  

									
	By:	 	 /s/ Jason Novi
	 		  	Date: 6/27/08	  	
		 	Jason B. Novi	 		  		  	

  
 

 
 Cell Biosciences, Inc. 

EMPLOYEE PROPRIETARY INFORMATION 

AND INVENTIONS AGREEMENT 
 In consideration of my
employment or continued employment by Cell Biosciences, Inc. (the “COMPANY”), and the compensation now and hereafter paid to me, I hereby agree as follows: 
  

	 	1.	NONDISCLOSURE 

  

	 	1.1	RECOGNITION OF COMPANY’S RIGHTS; NONDISCLOSURE. 

 At all times during my employment and
thereafter, I will hold in strictest confidence and will not disclose, use, lecture upon or publish any of the Company’s Proprietary Information (defined below), except as such disclosure, use or publication may be required in connection with
my work for the Company, or unless an officer of the Company expressly authorizes such in writing. I will obtain Company’s written approval before publishing or submitting for publication any material (written, verbal, or otherwise) that
relates to my work at Company and/or incorporates any Proprietary Information. I hereby assign to the Company any rights I may have or acquire in such Proprietary Information and recognize that all Proprietary Information shall be the sole property
of the Company and its assigns. 
  

	 	1.2	PROPRIETARY INFORMATION. 

 The term “PROPRIETARY INFORMATION” shall mean any and all
confidential and/or proprietary knowledge, data or information of the Company. By way of illustration but not limitation, “PROPRIETARY INFORMATION” includes (a) trade secrets, inventions, ideas, processes, formulas, source and object
codes, data, programs, other works of authorship, know-how, improvements, discoveries, developments, designs and techniques hereinafter collectively referred to as “INVENTIONS”); and (b) information regarding plans for research,
development, new products, marketing and selling, business plans, budgets and unpublished financial statements, licenses, prices and costs, suppliers and customers; and (c) information regarding the skills and compensation of other employees of
the Company. Notwithstanding the foregoing, it is understood that, at all such times, I am free to use information which is generally known in the trade or industry, which is not gained as result of a breach of this Agreement, and my own, skill,
knowledge, know-how and experience to whatever extent and in whichever way I wish. 
  

	 	1.3	THIRD PARTY INFORMATION. 

 I understand, in addition, that the Company has received and in the
future will receive from third parties confidential or proprietary information (“THIRD PARTY INFORMATION”) subject to a duty on the Company’s part to maintain the confidentiality of such information and to use it only for certain
limited purposes. During the term of my employment and thereafter, I will hold Third Party Information in the strictest confidence and will not disclose to anyone (other than Company personnel who need to know such information in connection with
their work for the Company) or use, except in connection with my work for the Company, Third Party Information unless expressly authorized by an officer of the Company in writing. 

  
 Page 1 of 8 

	 	1.4	NO IMPROPER USE OF INFORMATION OF PRIOR EMPLOYERS AND OTHERS. 

 During my employment by the
Company I will not improperly use or disclose any confidential information or trade secrets, if any, of any former employer or any other person to whom I have an obligation of confidentiality, and I will not bring onto the premises of the Company
any unpublished documents or any property belonging to any former employer or any other person to whom I have an obligation of confidentiality unless consented to in writing by that former employer or person. I will use in the performance of my
duties only information which is generally known and used by persons with training and experience comparable to my own, which is common knowledge in the industry or otherwise legally in the public domain, or which is otherwise provided or developed
by the Company. 
  

	 	2.	ASSIGNMENT OF INVENTIONS. 

  

	 	2.1	PROPRIETARY RIGHTS. 

 The term “PROPRIETARY RIGHTS” shall mean all trade secret,
patent, copyright, mask work and other intellectual property rights throughout the world. 
  

	 	2.2	PRIOR INVENTIONS. 

 Inventions, if any, patented or unpatented, which I made prior to the
commencement of my employment with the Company are excluded from the scope of this Agreement. To preclude any possible uncertainty, I have set forth on EXHIBIT B (Previous Inventions) attached hereto a complete list of all Inventions that I have,
alone or jointly with others, conceived, developed or reduced to practice or caused to be conceived, developed or reduced to practice prior to the commencement of my employment with the Company, that I consider to be my property or the property of
third parties and that I wish to have excluded from the scope of this Agreement (collectively referred to as “PRIOR INVENTIONS”). If disclosure of any such Prior Invention would cause me to violate any prior confidentiality agreement, I
understand that I am not to list such Prior Inventions in EXHIBIT B but am only to disclose a cursory name for each such invention, a listing of the party(ies) to whom it belongs and the fact that full disclosure as to such inventions has not been
made for that reason. A space is provided on EXHIBIT B for such purpose. If no such disclosure is attached, I represent that there are no Prior Inventions. If, in the course of my employment with the Company, I incorporate a Prior Invention into a
Company product, process or machine, the Company is hereby granted and shall have a nonexclusive, royalty-free, irrevocable, perpetual, worldwide license (with rights to sublicense through multiple tiers of sublicensees) to make, have made, modify,
use and sell such Prior Invention. Notwithstanding the foregoing, I agree that I will not incorporate, or permit to be incorporated, Prior Inventions in any Company Inventions without the Company’s prior written consent. 

 

	 	2.3	ASSIGNMENT OF INVENTIONS. 

 Subject to Sections 2.4, and 2.6, I hereby assign and agree to
assign in the future (when any such Inventions or Proprietary Rights are first reduced to practice or first fixed in a tangible medium, as applicable) to the Company all my right, title and interest in and to any and all Inventions (and all
Proprietary Rights with respect thereto) whether or not patentable or registrable under copyright or similar statutes, made or conceived or reduced to practice or learned by me, either alone or jointly with others, during the period of my employment
with the Company. Inventions assigned to the Company, or to a third party as directed by the Company pursuant to this Section 2, are hereinafter referred to as “COMPANY INVENTIONS.” 

 

	 	2.4	NONASSIGNABLE INVENTIONS. 

 This Agreement does not apply to an Invention that qualifies fully
as a nonassignable Invention under Section 2870 of the California Labor Code (hereinafter “SECTION 2870”). I have reviewed the notification on EXHIBIT A (Limited Exclusion Notification) and agree that my signature acknowledges receipt
of the notification. 

  
 Page 2 of 8 

	 	2.5	OBLIGATION TO KEEP COMPANY INFORMED. 

 During the period of my employment and for six
(6) months after termination of my employment with the Company, I will promptly disclose to the Company fully and in writing all Inventions authored, conceived or reduced to practice by me, either alone or jointly with others. In addition, I
will promptly disclose to the Company all patent applications filed by me or on my behalf within a year after termination of employment. At the time of each such disclosure, I will advise the Company in writing of any Inventions that I believe fully
qualify for protection under Section 2870; and I will at that time provide to the Company in writing all evidence necessary to substantiate that belief. The Company will keep in confidence and will not use for any purpose or disclose to third
parties without my consent any confidential information disclosed in writing to the Company pursuant to this Agreement relating to Inventions that qualify fully for protection under the provisions of Section 2870. I will preserve the
confidentiality of any Invention that does not fully qualify for protection under Section 2870. 
  

	 	2.6	GOVERNMENT OR THIRD PARTY. 

 I also agree to assign all my right, title and interest in and to
any particular Company Invention to a third party, including without limitation the United States, as directed by the Company. 
  

	 	2.7	WORKS FOR HIRE. 

 I acknowledge that all original works of authorship which are made by me
(solely or jointly with others) within the scope of my employment and which are protectable by copyright are “works made for hire,” pursuant to United States Copyright Act (17 U.S.C., Section 101). 

 

	 	2.8	ENFORCEMENT OF PROPRIETARY RIGHTS. 

 I will assist the Company in every proper way to obtain,
and from time to time enforce, United States and foreign Proprietary Rights relating to Company Inventions in any and all countries. To that end I will execute, verify and deliver such documents and perform such other acts (including appearances as
a witness) as the Company may reasonably request for use in applying for, obtaining, perfecting, evidencing, sustaining and enforcing such Proprietary Rights and the assignment thereof. In addition, I will execute, verify and deliver assignments of
such Proprietary Rights to the Company or its designee. My obligation to assist the Company with respect to Proprietary Rights relating to such Company Inventions in any and all countries shall continue beyond the termination of my employment, but
the Company shall compensate me at a reasonable rate after my termination for the time actually spent by me at the Company’s request on such assistance. 

In the event the Company is unable for any reason, after reasonable effort, to secure my signature on any document needed in connection with
the actions specified in the preceding paragraph, I hereby irrevocably designate and appoint the Company and its duly authorized officers and agents as my agent and attorney in fact, which appointment is coupled with an interest, to act for and in
my behalf to execute, verify and file any such documents and to do all other lawfully permitted acts to further the purposes of the preceding paragraph with the same legal force and effect as if executed by me. I hereby waive and quitclaim to the
Company any and all claims, of any nature whatsoever, which I now or may hereafter have for infringement of any Proprietary Rights assigned hereunder to the Company. 

  
 Page 3 of 8 

	 	2.9	COMPANY MATERIALS. 

 In addition to the foregoing, I understand that the Company possesses or
will possess “Company Materials” which are important to its business. For purposes of this Agreement, “Company Materials” are documents or other media or tangible items that contain or embody Proprietary Information or any other
information concerning the business, operations or plans of the Company, whether such documents have been prepared by me or by others. “Company Materials” include, without limitation, blueprints, drawings, photographs, charts, graphs,
notebooks, customer lists, computer software, media or printouts, sound recordings and other printed, typewritten or handwritten documents, as well as samples, prototypes, models, products, and the like. All Company Materials shall be the sole
property of the Company. I agree that during my employment by the Company, I will not physically or electronically remove or transmit any Company Materials from the business premises of the Company or deliver any Company Materials to any person or
entity outside the Company, except for a proper purpose in connection with performing the duties of my employment. I further agree that, immediately upon the termination of my employment by me or by the Company for any reason, or for no reason, or
during my employment if so requested by the Company, I will return all Company Materials, apparatus, equipment and other physical property, or any reproduction of such property, excepting only (i) my personal copies of records relating to my
compensation; (ii) my personal copies of any materials previously distributed generally to stockholders of the Company; and (iii) my copy of this Agreement. 
  

	 	3.	RECORDS. 

 I agree to keep and maintain adequate and current records (in the form of notes,
sketches, drawings and in any other form that may be required by the Company) of all Proprietary Information developed by me and all Inventions made by me during the period of my employment at the Company, which records shall be available to and
remain the sole property of the Company at all times. 
  

	 	4.	ADDITIONAL ACTIVITIES. 

 I agree that during the period of my employment by the Company I will
not, without the Company’s express written consent, engage in any employment or business activity that is in any way competitive with the business or proposed business of the Company, and I will not assist any other person or organization in
competing with the Company or in preparing to engage in competition with the business or proposed business of the Company. The provisions of this paragraph shall apply both during normal working hours and at all other times including, without
limitation, nights, weekends and vacation time, while I am employed by the Company. I agree further that for the period of my employment by the Company and for one (1) year after the date of termination of my employment by the Company I will
not induce any employee or consultant of the Company to leave the employ of the Company. 
  

	 	5.	NO CONFLICTING OBLIGATION. 

 I represent that my performance of all the terms of this Agreement
and as an employee of the Company does not and will not breach any agreement to keep in confidence information acquired by me in confidence or in trust prior to my employment by the Company. I have not entered into, and I agree I will not enter
into, any agreement either written or oral in conflict herewith. 
  

	 	6.	RETURN OF COMPANY DOCUMENTS. 

 When I leave the employ of the Company, I will deliver to the
Company any and all drawings, notes, memoranda, specifications, devices, formulas, and documents, together with all copies thereof, and any other material containing or disclosing any Company Inventions, Third Party Information or Proprietary
Information of the Company (including Company Materials). I further agree that any property situated on the Company’s premises and owned by the Company, including disks and other storage media, filing cabinets or other work areas, is subject to
inspection by Company personnel at any time with or without notice. Prior to leaving, I will cooperate with the Company in completing, and signing the Company’s termination statement. 

  
 Page 4 of 8 

	 	7.	LEGAL AND EQUITABLE REMEDIES. 

 Because my services are personal and unique and because I may
have access to and become acquainted with the Proprietary Information of the Company, the Company shall have the right to enforce this Agreement and any of its provisions by injunction, specific performance or other equitable relief, without bond
and without prejudice to any other rights and remedies that the Company may have for a breach of this Agreement. 
  

	 	8.	NOTICES. 

 Any notices required or permitted hereunder shall be given to the appropriate party
at the address specified below or at such other address as the party shall specify in writing. Such notice shall be deemed given upon personal delivery to the appropriate address or if sent by certified or registered mail, three (3) days after
the date of mailing. 
  

	 	9.	NOTIFICATION OF NEW EMPLOYER. 

 In the event that I leave the employ of the Company, I hereby
consent to the notification of my new employer of my rights and obligations under this Agreement. 
  

	 	10.	GENERAL PROVISIONS. 

  

	 	10.1	GOVERNING LAW; CONSENT TO PERSONAL JURISDICTION. 

 This Agreement will be governed by and
construed according to the laws of the State of California, as such laws are applied to agreements entered into and to be performed entirely within California between California residents. I hereby expressly consent to the personal jurisdiction of
the state and federal courts located in San Mateo County, California for any lawsuit filed there against me by Company arising from or related to this Agreement. 
  

	 	10.2	SEVERABILITY. 

 In case any one or more of the provisions contained in this Agreement shall, for
any reason, be held to be invalid, illegal or unenforceable in any respect, such invalidity, illegality or unenforceability shall not affect the other provisions of this Agreement, and this Agreement shall be construed as if such invalid, illegal or
unenforceable provision had never been contained herein. If moreover, any one or more of the provisions contained in this Agreement shall for any reason be held to be excessively broad as to duration, geographical scope, activity or subject, it
shall be construed by limiting and reducing it, so as to be enforceable to the extent compatible with the applicable law as it shall then appear. 
  

	 	10.3	SUCCESSORS AND ASSIGNS. 

 This Agreement will be binding upon my heirs, executors,
administrators and other legal representatives and will be for the benefit of the Company, its successors, and its assigns. 
  

	 	10.4	SURVIVAL. 

 The provisions of this Agreement shall survive the termination of my employment and
the assignment of this Agreement by the Company to any successor in interest or other assignee. 
  

	 	10.5	EMPLOYMENT. 

 I agree and understand that nothing in this Agreement shall confer any right with
respect to continuation of employment by the Company, nor shall it interfere in any way with my right or the Company’s right to terminate my employment at any time, with or without cause. 

 

	 	10.6	WAIVER. 

 No waiver by the Company of any breach of this Agreement shall be a waiver of any
preceding or succeeding breach. No waiver by the Company of any right under this Agreement shall be construed as a waiver of any other right. The Company shall not be required to give notice to enforce strict adherence to all terms of this
Agreement. 

  
 Page 5 of 8 

	 	10.7	ENTIRE AGREEMENT. 

 The obligations pursuant to Sections 1 and 2 of this Agreement shall apply
to any time during which I was previously employed, or am in the future employed, by the Company as a consultant if no other agreement governs nondisclosure and assignment of inventions during such period. This Agreement is the final, complete and
exclusive agreement of the parties with respect to the subject matter hereof and supersedes and merges all prior discussions between us; provided, however, that this Agreement does not set forth all the terms and conditions of my employment with the
Company. No modification of or amendment to this Agreement, nor any waiver of any rights under this Agreement, will be effective unless in writing and signed by the party to be charged. Any subsequent change or changes in my duties, salary or
compensation will not affect the validity or scope of this Agreement. 
 This Agreement shall be effective as of the first day of my employment with the
Company, namely: June 27, 2008. 
 I HAVE READ THIS AGREEMENT CAREFULLY AND UNDERSTAND ITS TERMS. I HAVE COMPLETELY FILLED OUT EXHIBIT B TO THIS
AGREEMENT. 
 Dated: June 27, 2008 
  

	
	 /s/ Jason Novi

	(SIGNATURE)
	
	 Jason Novi

	(PRINTED NAME)
	
	ACCEPTED AND AGREED TO:
	
	Cell Biosciences, Inc.
	
	By:
	  

	
	Title:
	  

	
	  

	(Address)
	  

	
	Dated:
	  

  
 Page 6 of 8 

 EXHIBIT A 
 LIMITED
EXCLUSION NOTIFICATION 
 THIS IS TO NOTIFY you in accordance with Section 2872 of the California Labor Code that the foregoing Agreement between you
and the Company does not require you to assign or offer to assign to the Company any invention that you developed entirely on your own time without using the Company’s equipment, supplies, facilities or trade secret information except for those
inventions that either: 
  

	 	1.	Relate at the time of conception or reduction to practice of the invention to the Company’s business, or actual or demonstrably anticipated research or development of the Company; 

	 	2.	Result from any work performed by you for the Company. 

 To the extent a provision in the foregoing Agreement
purports to require you to assign an invention otherwise excluded from the preceding paragraph, the provision is against the public policy of this state and is unenforceable. 

This limited exclusion does not apply to any patent or invention covered by a contract between the Company and the United States or any of its agencies
requiring full title to such patent or invention to be in the United States. 
 I ACKNOWLEDGE RECEIPT of a copy of this notification. 

 

			
	By:	 	/s/ Jason Novi
	
	 Jason Novi

	(PRINTED NAME OF EMPLOYEE)
		
	Date:	 	June 27, 2008
	
	WITNESSED BY:
	  

	(PRINTED NAME OF REPRESENTATIVE)

  
 Page 7 of 8 

 EXHIBIT B 
  

									
	TO:	  	Cell Biosciences, Inc.
		
	FROM:	  	Jason Novi
		
	DATE:	  	June 27, 2008
		
	SUBJECT:	  	PREVIOUS INVENTIONS
		
	1.	  	Except as listed in Section 2 below, the following is a complete list of all inventions or improvements relevant to the subject matter of my employment by Cell Biosciences, INC., (the “COMPANY”) that have
been made or conceived or first reduced to practice by me alone or jointly with others prior to my engagement by the Company:
		
	x	  	No inventions or improvements.
		
	 ̈	  	See below:
		  	  
	    		    		  	
		  	  
	    		    		  	
		  	  
	    		    		  	
		
	 ̈	  	Additional sheets attached.
		
	2.	  	Due to a prior confidentiality agreement, I cannot complete the disclosure under Section 1 above with respect to inventions or improvements generally listed below, the proprietary rights and duty of confidentiality
with respect to which I owe to the following party(ies):
					
		  	INVENTION OR IMPROVEMENT	    	PARTY (IES)	    	RELATIONSHIP	  	
	 1.
	  	  
	    	  
	    	  
	  	
	 2.
	  	  
	    	  
	    	  
	  	
	 3.
	  	  
	    	  
	    	  
	  	
		
	  ̈.
	  	Additional sheets attached.

  
 Page 8 of 8

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00230-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00230-of-00352.parquet"}]]